Cargando…

Language disturbances in schizophrenia: the relation with antipsychotic medication

Language disturbances are key aberrations in schizophrenia. Little is known about the influence of antipsychotic medication on these symptoms. Using computational language methods, this study evaluated the impact of high versus low dopamine D(2) receptor (D2R) occupancy antipsychotics on language di...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Boer, J. N., Voppel, A. E., Brederoo, S. G., Wijnen, F. N. K., Sommer, I. E. C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477551/ https://www.ncbi.nlm.nih.gov/pubmed/32895389 http://dx.doi.org/10.1038/s41537-020-00114-3

Ejemplares similares

Acoustic speech markers for schizophrenia-spectrum disorders: a diagnostic and symptom-recognition tool
por: de Boer, J. N., et al.
Publicado: (2023)

Language in schizophrenia: relation with diagnosis, symptomatology and white matter tracts
por: de Boer, J. N., et al.
Publicado: (2020)

T59. ACOUSTIC SPEECH MARKERS FOR SCHIZOPHRENIA
por: de Boer, Janna, et al.
Publicado: (2020)

Antipsychotic medication for women with schizophrenia spectrum disorders
por: Brand, Bodyl A., et al.
Publicado: (2022)

S136. CLASSIFYING SCHIZOPHRENIA USING PHONOLOGICAL, SEMANTIC AND SYNTACTIC FEATURES OF LANGUAGE; A COMBINATORY MACHINE LEARNING APPROACH
por: Voppel, Alban, et al.
Publicado: (2020)

Antipsychotic medication for women with schizophrenia spectrum disorders – CORRIGENDUM
por: Brand, Bodyl A., et al.
Publicado: (2023)

Evaluating computational models of language disturbance in schizophrenia
por: Grasemann, Uli, et al.
Publicado: (2010)

Fragmented sleep relates to hallucinations across perceptual modalities in the general population
por: Brederoo, Sanne G., et al.
Publicado: (2021)

Metabolic Disturbances Independent of Body Mass in Patients with Schizophrenia Taking Atypical Antipsychotics
por: Kang, Shi Hyun, et al.
Publicado: (2015)

Predictors of switching antipsychotic medications in the treatment of schizophrenia
por: Nyhuis, Allen W, et al.
Publicado: (2010)

Social Deafferentation and the Relation Between Loneliness and Hallucinations
por: Brederoo, Sanne G, et al.
Publicado: (2023)

Language and Language Disturbances
por: Pribram, K. H.
Publicado: (1949)

The Therapeutic Relationship and Adherence to Antipsychotic Medication in Schizophrenia
por: McCabe, Rosemarie, et al.
Publicado: (2012)

Metabolic disturbances associated with antipsychotic drug treatment in patients with schizophrenia: State-of-the-art and future perspectives
por: Chang, Shen-Chieh, et al.
Publicado: (2021)

Swithching Antipsychotic Medications in People with Schizophrenia: A 4-Year Naturalistic Study
por: Ceres, R., et al.
Publicado: (2023)

PM393. Antipsychotic polypharmacy patterns and antipsychotic psychiatric medication adherence in patients with schizophrenia
por: Joe, Soohyun, et al.
Publicado: (2016)

The linguistics of schizophrenia: thought disturbance as language pathology across positive symptoms
por: Hinzen, Wolfram, et al.
Publicado: (2015)

The tyrosine phosphatase STEP: implications in schizophrenia and the molecular mechanism underlying antipsychotic medications
por: Carty, N C, et al.
Publicado: (2012)

Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies
por: Haddad, Peter M, et al.
Publicado: (2014)

Severity in schizophrenia patients receiving atypical antipsychotic medications
por: Alam Fatmi1j, Syed Meraj, et al.
Publicado: (2022)

Antipsychotic agents: efficacy and safety in schizophrenia
por: de Araújo, Arão Nogueira, et al.
Publicado: (2012)

Cost of antipsychotic polypharmacy in the treatment of schizophrenia
por: Zhu, Baojin, et al.
Publicado: (2008)

Entorhinal Cortex Volume in Antipsychotic-naïve Schizophrenia
por: Jose, Sam P., et al.
Publicado: (2012)

Thalamic Shape Abnormalities in Antipsychotic Naïve Schizophrenia
por: Danivas, Vijay, et al.
Publicado: (2013)

Antipsychotic medications and stroke in schizophrenia: A case-crossover study
por: Chen, Wen-Yin, et al.
Publicado: (2017)

Prevalence of metabolic syndrome in schizophrenia patients treated with antipsychotic medications
por: Jaberi, Nayyer, et al.
Publicado: (2020)

Effects of antipsychotic and anticholinergic medications on cognition in chronic patients with schizophrenia
por: Haddad, Chadia, et al.
Publicado: (2023)

Auditory hallucinations, top-down processing and language perception: a general population study
por: de Boer, J. N., et al.
Publicado: (2019)

Longitudinal Changes in Total Brain Volume in Schizophrenia: Relation to Symptom Severity, Cognition and Antipsychotic Medication
por: Veijola, Juha, et al.
Publicado: (2014)

Antipsychotic medication-mediated cognitive change in schizophrenia and polygenic score for cognitive ability
por: Blackman, Rachael K., et al.
Publicado: (2021)

Use of Conventional Antipsychotics and the Cost of Treating Schizophrenia
por: Lyu, Ramon R., et al.
Publicado: (2001)

Abnormal synaptic pruning during adolescence underlying the development of psychotic disorders
por: Germann, Monique, et al.
Publicado: (2021)

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
por: Faries, Douglas, et al.
Publicado: (2005)

Progress in Genetic Polymorphisms Related to Lipid Disturbances Induced by Atypical Antipsychotic Drugs
por: Li, Nana, et al.
Publicado: (2020)

Estrogens in schizophrenia: progress, current challenges and opportunities
por: Brand, Bodyl A., et al.
Publicado: (2021)

PMH26 Early Impact of COVID-19 Pandemic on Antipsychotic Medication Use Among Patients with Schizophrenia
por: Pesa, J., et al.
Publicado: (2021)

Non-adherence to antipsychotic medication, relapse and rehospitalisation in recent-onset schizophrenia
por: Morken, Gunnar, et al.
Publicado: (2008)

Systematic review of the economic aspects of nonadherence to antipsychotic medication in patients with schizophrenia
por: Dilla, Tatiana, et al.
Publicado: (2013)

Antipsychotic medication non-adherence among schizophrenia patients in Central Ethiopia
por: Tareke, Minale, et al.
Publicado: (2018)

Correction: Antipsychotic medications and stroke in schizophrenia: A case-crossover study
por: Chen, Wen-Yin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0k03fgftgs3u5m6au8eqvshfst